Company Monitoring Page for GSK

latest headlines for company on cafepharma

The race for gold: Closing in on the first RSV vaccine
Pharmaphorum
Wed, 05/3/23 - 11:37 am
Tags:
vaccines, RSV, GSK, Pfizer, Moderna Therapeutics
'More in the hopper': European Big Pharmas hint M&A could ramp up
Fierce Biotech
Mon, 05/1/23 - 10:15 am
Tags:
Europe, M&A, GSK, Novartis, Roche
GSK's RSV vaccine first to get EU regulator's nod
Reuters
Fri, 04/28/23 - 10:12 am
Tags:
GSK, vaccines, RSV, Europe
As FDA decision nears, GSK projects 'Shingrix-like' sales for its RSV vaccine prospect
Fierce Pharma
Wed, 04/26/23 - 05:38 pm
Tags:
GSK, RSV, vaccines
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
Tags:
R&D, AbbVie, Amgen, AstraZeneca, Bayer, Biogen, Bristol Myers Squibb, Eli Lilly, Gilead Sciences, GSK, JNJ, Merck, Merck KGaA, Moderna Therapeutics, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi, UCB, Vertex Pharmaceuticals
Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
Fri, 04/21/23 - 10:00 am
Tags:
M&A, R&D, AbbVie, AstraZeneca, Bristol Myers Squibb, Eli Lilly, GSK, JNJ, Merck, Novartis, Pfizer, Roche, Sanofi
GSK faces strike threat in UK, again, after workers pan pay raise
Fierce Pharma
Wed, 04/19/23 - 09:57 pm
Tags:
GSK, UK, strike
Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A
Fierce Pharma
Tue, 04/18/23 - 10:10 pm
Tags:
Big Pharma, M&A, Merck, Prometheus Biosciences, GSK, Bellus Health
GSK coughs up $2B for Bellus Health
Medical Marketing and Media
Tue, 04/18/23 - 10:24 am
Tags:
GSK, Bellus Health, M&A, chronic cough, Camlipixant
GSK's gepotidacin shows potential in urinary tract infections
Marketscreener
Mon, 04/17/23 - 11:39 am
Tags:
GSK, antibiotics, UTIs, gepotidacin
Can Pfizer Beat GSK and Moderna in This $10 Billion Market?
Motley Fool
Thu, 04/13/23 - 11:50 am
Tags:
Pfizer, GSK, Moderna Therapeutics
GSK outlines deal to send cell therapies back to Adaptimmune
BioPharma Dive
Tue, 04/11/23 - 11:41 am
Tags:
GSK, Adaptimmune Therapeutics, cancer, cell therapy
GSK told to pay higher royalties to AZ on Zejula sales
Pharmaphorum
Thu, 04/6/23 - 11:37 am
Tags:
GSK, AstraZeneca, ovarian cancer, Zejula, legal, UK
5 FDA decisions to watch in the second quarter
BioPharma Dive
Mon, 04/3/23 - 11:06 pm
Tags:
FDA, Sarepta Therapeutics, Duchenne Muscular Dystrophy, Biogen, tofersen, ALS, Seres Therapeutics, C. difficile, Pfizer, GSK, vaccines, RSV, Regeneron, Eylea
Could This Move by Johnson & Johnson Equal Billions for Moderna?
Motley Fool
Sun, 04/2/23 - 04:19 pm
Tags:
JNJ, Moderna Therapeutics, Pfizer, GSK, RSV, vaccines
In Teva vs. GSK skinny label feud, Biden admin urges Supreme Court to weigh in
Fierce Pharma
Fri, 03/31/23 - 10:39 am
Tags:
GSK, Teva Pharmaceutical, legal, Supreme Court, skinny labels
SCYNEXIS Skyrockets on Teaming Up With GSK for Fungal Treatment
Tip Ranks
Thu, 03/30/23 - 10:14 am
Tags:
Scynexis, GSK, antifungals, Brexafemme
J&J bows out of RSV vaccine race after scrapping trial
Yahoo/Reuters
Wed, 03/29/23 - 10:07 am
Tags:
JNJ, RSV, vaccines, clinical trials, Pfizer, GSK
In new PD-1 showdown, GSK's Jemperli loses initial edge on Merck's Keytruda
Fierce Pharma
Mon, 03/27/23 - 10:09 pm
Tags:
GSK, Merck, Keytruda, Jemperli, cancer
GSK plays defense after California judge approves plaintiff's expert testimony in high-stakes Zantac trial
Fierce Pharma
Sun, 03/26/23 - 11:21 pm
Tags:
GSK, Zantac, California, legal

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.